How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome
Launched by MICHIGAN STATE UNIVERSITY · Apr 22, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different ways of using language can help young children with Down syndrome learn and understand better. Specifically, researchers want to see if using single words or short phrases (called telegraphic speech) is as effective as using full sentences when teaching new words. They will look at how these different language styles affect how quickly and accurately children can process what they hear and how well they can learn new words. The study will also explore if certain characteristics, like a child's existing language skills or thinking abilities, influence how well they respond to these different types of language.
To participate in this trial, children need to be between 2 to 7 years old, have Down syndrome, and speak English as their main language. Children who have other conditions like brain injury, cerebral palsy, or uncorrected vision or hearing problems won't be eligible. During the study, participants will engage in activities designed to help researchers understand how they process and learn language in these different formats. This research aims to improve language teaching strategies for children with Down syndrome, ultimately helping them to communicate more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Down syndrome
- • English as primary language
- • 2-7 years old
- Exclusion Criteria:
- • Acquired brain injury
- • Cerebral palsy
- • Uncorrected vision or hearing impairment
About Michigan State University
Michigan State University (MSU) is a leading public research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, MSU integrates cutting-edge research methodologies and expert faculty across various fields to address pressing health challenges. The university's commitment to ethical research practices and participant safety ensures that all clinical trials are conducted with the highest standards of integrity and compliance. By fostering a dynamic environment for scientific inquiry, MSU aims to translate research findings into practical solutions that enhance patient care and contribute to the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
East Lansing, Michigan, United States
Patients applied
Trial Officials
Courtney Venker, PhD
Principal Investigator
Michigan State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported